Invention Grant
- Patent Title: Bispecific antigen binding molecules targeting OX40 and FAP
-
Application No.: US17218948Application Date: 2021-03-31
-
Publication No.: US11780919B2Publication Date: 2023-10-10
- Inventor: Maria Amann , Juergen Peter Bachl , Alexander Bujotzek , Carina Cantrill , Harald Duerr , Janine Faigle , Sabine Imhof-Jung , Christian Klein , Thomas Kraft , Estelle Marrer-Berger , Ekkehard Moessner , Laurene Pousse , Petra Rueger , Johannes Sam , Roland Staack , Dietrich Tuerck , Pablo Umana , Joerg Zielonka
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Lawrence S. Graham
- Priority: EP 167624 2020.04.01
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; A61P35/00 ; A61K45/06 ; C07K16/30 ; C07K16/46
Abstract:
The invention relates to novel bispecific antigen binding molecules, comprising at least two antigen binding domains capable of specific binding to OX40 and a particular antigen binding domain capable of specific binding to Fibroblast Activation Protein (FAP), and to methods of producing these molecules and to methods of using the same.
Public/Granted literature
- US20220025046A1 BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP Public/Granted day:2022-01-27
Information query
